Navigation Links
Versatile Transfection Reagent Offers Low Toxicity and Consistent,,,Performance


LipoTAXI transfection reagent: A proven choice

Matt C. Petre
Stratagene

LipoTAXI transfection reagent offers improved, consistent transfections for both adherent cells and cells growing in suspension. In this article, we summarize the results of several experiments that characterize the effectiveness of LipoTAXI reagent. Optimizing transfection conditions is a critical, preliminary step to achieving high transfection efficiencies, a need supported by data showing that transfection efficiencies vary with different cell lines and different lipid-transfection reagents. In addition, we examine the effect of mycoplasma contamination of cell lines on transfection efficiency. Finally, we show that LipoTAXI reagent is superior by comparing it to another lipid-based transfection reagent. Together, these studies confirm the high efficiency and low toxicity of LipoTAXI transfection reagent.

Using transfection procedures to introduce foreign DNA into mammalian cells is integral to many research endeavors. Consequently, focused efforts are directed toward improving transfection technology. Lipid-mediated transfection reagents have improved the technology because they are easy to use, gentle to cells, and yield consistent results.1,2 However, even for lipid-based procedures, a variety of factors can influence transfection efficiency. These include DNA concentration,3 choice and volume of transfection reagent,4 choice of cell line,5 and presence of mycoplasma contamination6.

To achieve high transfection efficiencies, we advise researchers using Stratagenes LipoTAXI transfection reagent to experimentally determine the concentration of DNA and volume of LipoTAXI transfection reagent. To optimize transfection in any cell type, it is standard to measure the signal inten
'"/>

Source:


Page: All 1 2 3 4 5 6 7

Related biology technology :

1. A Versatile Power Supply for All Electrophoresis Applications
2. Versatile Vectors for Ponasterone A- Inducible Control of Gene Expression in Mammalian Cells
3. Versatile Reporter Vectors for Monitoring Viral Transduction
4. pSilencer 4.1-CMV: Versatile Vectors for Expression of siRNA, miRNA, and mRNA
5. Highest Transfection Efficiency of an Endotoxin-Sensitive Mammalian Cell Line
6. Optimizing Transfection Conditions for Studying Signal Transduction Pathways
7. Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells
8. Improve Lipid- or Calcium Phosphate-Mediated Transfection of Human Dermal Fibroblasts
9. Low-Toxicity, Lipid-Mediated Transfection of Mammalian Cells
10. Mycoplasma Contamination Reduces the Effect of Lipid-Mediated Transfection of Mammalian Cells
11. High-Efficiency Transfections Achieved with New Low-Toxicity Reagent

Post Your Comments:
(Date:11/19/2009)...FirstCall/ -- Omeros Corporation (Nasdaq: OMER ) ...e third quarter ended September 30, 2009. For the ...rted a net loss of $3.9 million, or $1.34 per shar...2.54 per share, for the same period in 2008. For t...ny reported a net loss of $15.5 million, or $5.29 ...
(Date:11/19/2009)...-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS ), a...er to its shareholders, discussing the Company,s a...aceuticals Holdings, Inc. (CHBP), an integrated bi...ublic of China. The merger gives NeoStem a control.... Ltd., CHBP,s primary operating subsidiary and a ...
(Date:11/19/2009)...mber 19 MONITORING FORCE GmbH,anno...Flibanserin in the,indication treatment-relevant l...for orphan drug status designation with the Europe...nesia is a complication of the mainstay,treatment ...me of those,affected, since it may be disabling fo...
(Date:11/19/2009)...ne Synthesis Companies Form International Gene Syn...ces in Risk Reduction ,Five Member Companies Rep...city , (PRWEB) November 1...synthesis companies today announced agreement that...omote biosecurity in the gene synthesis industry. ...
Breaking Biology Technology:Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4
...iness unit of PAREXEL International (Nasdaq: PRXL...serving the bio/pharmaceutical and medical device,...ng its Good Manufacturing,Practice (GMP) capabilit...ss complexities of European Union (EU) directives ...y, and safety. This initiative includes the addit...
...ay never get smaller than this. , Physicists at ...e-atom thick sheet of carbon atoms arranged in hex...table, with electric charges acting as billiard ba...al for serving as an excellent electronic material... kinds of transistors based on quantum physics. Be...
...e-FirstCall/ -- 3SBio Inc.,(Nasdaq: SSRX ), a lea...researching, developing, manufacturing and marketi... UBS Global Life Sciences Conference in New,York o...e presentation will be webcast live and can be acc...of the 3SBio website at, http://bbs.3sbio.com/en/N...
Other Biology Technology:Parexel Consulting Strengthens Good Manufacturing Practice Capabilities in Europe 2Parexel Consulting Strengthens Good Manufacturing Practice Capabilities in Europe 3Parexel Consulting Strengthens Good Manufacturing Practice Capabilities in Europe 4Parexel Consulting Strengthens Good Manufacturing Practice Capabilities in Europe 5Parexel Consulting Strengthens Good Manufacturing Practice Capabilities in Europe 6Sheet of carbon atoms acts like a billiard table, physicists find 2
(Date:11/20/2009)...PD), a respiratory disease commonly known as chron...cause of death worldwide. 600 million people live...any real treatment or cure, Grace Parraga of Robar... Ontario in London, Canada, is using various imagi.... , Parraga is a scientist in the Imaging Re...
(Date:11/19/2009)...e fungus for food, have many remarkable qualities.... farmers, like their human counterparts, depend on...ow. The finding, reported this week (Nov. 20) in t...wn symbiosis between ants and bacteria and provide...ominate the American tropics and subtropics. , W...
(Date:11/19/2009)...in maize, also known as corn, researchers across t...hould pave the way to significant improvements in ...al feed and fiber around the world. , The new ma... map, charts genetic diversity and recombination a...research team, led by U.S. Department of Agricultu...
Breaking Biology News(10 mins):Gaining a better picture of lung disease 2Like humans, ants use bacteria to make their gardens grow 2Online Think Tank Big Think Launches New Multimedia Web Series Exploring Some of the Most Pressing Science and Medical Issues of our Time 54988 1Online Think Tank Big Think Launches New Multimedia Web Series Exploring Some of the Most Pressing Science and Medical Issues of our Time 54988 2Online Think Tank Big Think Launches New Multimedia Web Series Exploring Some of the Most Pressing Science and Medical Issues of our Time 54988 3Online Think Tank Big Think Launches New Multimedia Web Series Exploring Some of the Most Pressing Science and Medical Issues of our Time 54988 4NASA researcher nets first measure of Africas coastal forests 9644 1NASA researcher nets first measure of Africas coastal forests 9644 2NASA researcher nets first measure of Africas coastal forests 9644 3NASA researcher nets first measure of Africas coastal forests 9644 4Fattah Advocates D C March for Healthcare By the Supporters of Reform with Public Option 54984 1
...investment in bioenergy research has been announce...r the biosciences the Biotechnology and Biologica...BSRC Sustainable Bioenergy Centre has been launche...he important and emerging UK sustainable bioenergy...h fuels derived from plants. , Sustainable bioen...
...SVOX, the leading provider of,embedded speech solu...ssional,Speech Processing Group of Siemens AG, acc...ed all speech technology-related IP of Siemens AG ...ce(TM) speech recognition product,suite and more t...sional,Speech Processing Group,s employees will be...
...rs at Cold Spring Harbor Laboratory (CSHL) announc...s. At the same time, they reported that their disc...biochemical pathway for RNA processing in which th...e research, which is part of a multinational proje...ning the biological function of the new short RNA ...
Other Biology News:Biggest ever public investment in bioenergy to help provide clean, green and sustainable fuels 2SVOX Acquires Speech Processing Unit of Siemens AG, Expands Into Speech Recognition and Speech Dialog 2CSHL scientists find a new class of small RNAs and define its function 2CSHL scientists find a new class of small RNAs and define its function 3
Rabbit Anti-Human Naked1 Polyclonal Antibody, Unconjugated from Cell Signaling Technology
Rabbit Anti-NF-kB p65, phospho (Ser345) Antibody, Unconjugated from Spring Bioscience
Anti-NSP-C (Neuroendocrine-Specific-Protein) Monoclonal Antibody, Unconjugated, Clone RNL-4 from CHEMICON
Rabbit Anti-Human ADAMTS-4, disintegrin-like domain Antibody, Unconjugated from CHEMICON
Biology Products: